Phosphorylation of Tau protein correlates with changes in hippocampal theta oscillations and reduces hippocampal excitability in Alzheimer's model.
|Title||Phosphorylation of Tau protein correlates with changes in hippocampal theta oscillations and reduces hippocampal excitability in Alzheimer's model.|
|Publication Type||Journal Article|
|Year of Publication||2018|
|Authors||Mondragon-Rodriguez S, Salas-Gallardo A, González-Pereyra P, Macías M, Ordaz B, Peña-Ortega F, Aguilar-Vázquez A, Orta-Salazar E, Díaz-Cintra S, Perry G, Williams S|
|Journal||J Biol Chem|
|Date Published||2018 Jun 01|
Tau hyperphosphorylation at several sites, including those close to the microtubule domain region (MDr), is considered a key pathological event in the development of Alzheimer's disease (AD). Recent studies indicate that at the very early stage of this disease, increased phosphorylation in Tau's MDr domain correlates with reduced levels of neuronal excitability. Mechanistically, we show that pyramidal neurons and some parvalbumin-positive interneurons in 1-month-old triple-transgenic AD mice accumulate hyperphosphorylated Tau protein and that this accumulation correlates with changes in theta oscillations in hippocampal neurons. Pyramidal neurons from young triple-transgenic AD mice exhibited less spike accommodation and power increase in subthreshold membrane oscillations. Furthermore, triple-transgenic AD mice challenged with the potassium channel blocker 4-aminopyridine had reduced theta amplitude compared with 4-aminopyridine-treated control mice and, unlike these controls, displayed no seizure-like activity after this challenge. Collectively, our results provide new insights into AD pathogenesis and suggest that increases in Tau phosphorylation at the initial stages of the disease represent neuronal responses that compensate for brain circuit overexcitation.
|Alternate Journal||J. Biol. Chem.|
|PubMed Central ID||PMC5986208|
|Grant List||G12 MD007591 / MD / NIMHD NIH HHS / United States|